β-secretase inhibitor; a promising novel therapeutic drug in Alzheimer’s disease

Alzheimer’s disease (AD) and vascular dementia are responsible for up to 90% of dementia cases. According to the World Health Organization (WHO), a staggering number of 35.6 million people are currently diagnosed with dementia. Blocking disease progression or preventing AD altogether is desirable fo...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Menting, Kelly Willemijn, Claassen, Jurgen A. H. R.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2014
Ämnen:
Neuroscience
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4104928/
https://ncbi.nlm.nih.gov/pubmed/25100992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2014.00165
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk